Search for: "CASE V. HATCH"
Results 21 - 40
of 1,020
Sorted by Relevance
|
Sort by Date
6 May 2007, 9:06 pm
New Cases Added: Avelox: Bayer v. [read post]
25 Jan 2007, 7:16 pm
New cases added: Cosopt: Merck v. [read post]
5 Nov 2006, 8:29 pm
Cases added: Actonel--Procter & Gamble v. [read post]
3 Apr 2018, 5:15 am
Bayer AG v. [read post]
3 Apr 2013, 4:45 am
I don’t know if you would call me an expert, but I’ve studied many, many cases involving Paragraph IV Certifications under Hatch-Waxman. [read post]
2 Apr 2007, 9:52 pm
For the latest version of the Hatch-Waxman Tracker, click here. [read post]
2 Mar 2012, 8:17 am
" Braintree Laboratories Inc. v. [read post]
7 May 2009, 9:56 am
FergusonPlessy v. [read post]
7 Aug 2012, 7:27 am
While the Supreme Court may have expanded the reach of the Hatch-Waxman “safe harbor,” the Medtronic and Merck cases only involved pre-marketing FDA approval activity. [read post]
7 Aug 2012, 7:27 am
While the Supreme Court may have expanded the reach of the Hatch-Waxman “safe harbor,” the Medtronic and Merck cases only involved pre-marketing FDA approval activity. [read post]
9 Apr 2014, 7:03 am
United Therapeutics Corporation v. [read post]
4 Sep 2020, 5:14 am
In 1947 in the case United Public Workers of America v. [read post]
10 Nov 2020, 4:15 am
” Valeant Pharmaceuticals v. [read post]
7 Aug 2012, 7:27 am
While the Supreme Court may have expanded the reach of the Hatch-Waxman “safe harbor,” the Medtronic and Merck cases only involved pre-marketing FDA approval activity. [read post]
18 Apr 2024, 7:49 am
The worst-case scenario is easy to envision based on opinions to date. [read post]
24 Jun 2013, 6:08 am
In FTC v. [read post]
20 Feb 2013, 7:37 am
Bristol-Myers Squibb Company v. [read post]
8 Aug 2008, 1:35 am
Proveris Scientific Corp. v. [read post]
2 Apr 2015, 9:59 pm
Daiichi Sankyo, Inc. case, at least if you are in the wild world of the Hatch-Waxman statute. [read post]
18 Apr 2012, 9:12 pm
By Andrew Williams -- In a second case involving the Hatch-Waxman regulatory scheme decided by the Federal Circuit on Monday, the Court held in Bayer Schering Pharma AG v. [read post]
